Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Yilmaz, M. Karaman, F. Firinci, A. Turkeli, E. Toprak, S. Inan, H. Yuksel (Manisa, Izmir, Turkey). Influence of different asthma treatments on TSLP, foxp3 and ZO-1 proteins reflecting inflammation and epithelial barrier function. Eur Respir J 2013; 42: Suppl. 57, 576

Member's Comments

No comment yet.

Related content which might interest you: Changes in epithelial barrier components E-cadherin, Beta-catenin, EGR with steroid treatment in murine model of asthma Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 PCDH1: Localization and cell-adhesion in airway epithelium in asthma Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 Airway surface dehydration confers susceptibility to allergic airway inflammation in vivo Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 IL-25 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma model Source: International Congress 2015 – Asthma and lung immunology Year: 2015 The HMGB1-RAGE axis is critical in the process of allergic sensitization Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 IL-25 receptor expression on basophil membrane is related to phenotype and severity of asthma Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Differential expression of uPAR in cultured bronchial epithelial cells from asthma patients Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 Azithromycin differentially affects IL-13 induced periostin (POSTN), CLCA1 and SERPINB2 expression in human bronchial epithelial cells Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 The capacity of human airway epithelium to regulate T cell proliferation is reduced in asthma Source: International Congress 2015 – Asthma mechanisms and management Year: 2015 Immunohistochemical study on changes of mast cell populations during allergic airway inflammation in mice using HDM model Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Human lung mast cells alter asthmatic airway epithelial cell function Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013 IL-4 induced changes in the Wnt signalling of bronchial epithelial cells Source: International Congress 2015 – Asthma mechanisms and management Year: 2015 Adipose derived stem cells ameliorate airway inflammation in mouse models of asthma Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Cellular mechanisms underlying CCSP SNP association with chronic airway diseases Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Side effects of tacrolimus upon airway epithelial tissue Source: Annual Congress 2013 –Clinical studies in lung transplantation Year: 2013 Enhanced inflammatory gene expression in bronchial epithelial cells from asthmatic patients: Attenuation by a Brd4 mimic Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Periostin: A key contributor to changes in the epithelial phenotype in asthma? Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Human mast cells and type 2 innate lymphoid cells activate gene expression and mucus composition in human bronchial epithelial cells via IL-13 Source: International Congress 2014 – Mechanistic studies of the airway epithelium Year: 2014 IL-8 and TSLP production as markers of bronchial epithelial cell activation in IL-17A mediated airway inflammation in COPD: Role of tiotropium Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung Year: 2013 Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015